We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Mechanism Explains Increased Insulin Resistance in Type II Diabetes

By LabMedica International staff writers
Posted on 11 Apr 2012
A recent paper outlined the molecular mechanism that makes the p75 neurotrophin receptor (p75NTR) a key regulator of glucose uptake and insulin resistance and suggested a possible new therapeutic approach for the treatment of type II diabetes.

Investigators at the University of California, San Francisco (USA) identified p75NTR as being associated with glucose regulation due to its location in fat and muscle tissue and its participation in many aspects of cell metabolism. More...
To examine more precisely the role of p75NTR they genetically engineered a line of mice to lack the gene that produces this protein.

Results published in the March 28, 2012, online edition of the journal Proceedings of the [US] National Academy of Sciences revealed that compared to normal animals, the p75NTR “knockout” mice demonstrated increased insulin sensitivity on normal chow diet, independent of changes in body weight. Deletion of the p75NTR gene increased the insulin-stimulated glucose disposal rate and suppression of hepatic glucose production.

Other mice were manipulated to overexpress p75NTR in their adipocytes. In these animals, insulin-stimulated glucose transport was decreased. In adipocytes, p75NTR was found to form a complex with the Rab5 family GTPases Rab5 and Rab31 that regulate the activity of the glucose transport protein GLUT4. Rab5 and Rab31 directly interacted with p75NTR primarily via helix 4 of the p75NTR death domain. Adipocytes from p75NTR knockout mice showed increased Rab5 and decreased Rab31 activities, and dominant negative Rab5 rescued the increase in glucose uptake seen in p75NTR knockout adipocytes.

“We identified that p75NTR is a unique player in glucose metabolism,” said senior author Dr. Katerina Akassoglou, associate professor of neurology at the University of California, San Francisco. “Therapies targeted at p75NTR may represent a new therapeutic approach for diabetes, and our studies of p75NTR's unanticipated role in regulating glucose metabolism suggest a new target for drug therapies. Future work is needed to test whether this finding may translate into a potential treatment.”

Related Links:
University of California, San Francisco




New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Laboratory Software
ArtelWare
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The cell-based tests bring artificial intelligence to transplant outcome care (Photo courtesy of iStock)

AI-Enhanced Cell-Based Blood Tests to Improve Predictive Accuracy for Complex Transplant Outcomes

Managing immunosuppressive drugs in transplant patients is a delicate challenge. Insufficient medication can lead to rejection, which may be cell- or antibody-mediated, while excess immunosuppression raises... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: A saliva test can help predict future metabolic health concerns including diabetes and obesity (Photo courtesy of 123RF)

Saliva Test to Enable Early Detection of Diabetes and Obesity

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. However, conditions like insulin resistance and hyperinsulinemia may begin developing... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.